Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2016-01-22FDA Approved: ESCITALOPRAM — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for escitalopram from Rising Pharma Holdings, Inc.
-
FDA approval · 2016-01-20FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Zydus Pharmaceuticals USA Inc.)
FDA approves a supplemental application for venlafaxine hydrochloride submitted by Zydus Pharmaceuticals USA Inc., resulting in regulatory a…
-
FDA approval · 2016-01-20FDA Approved: DOXEPIN — Original Application (North Star Rx LLC)
FDA approved North Star Rx LLC's generic doxepin through an Original Application, marking the approval of a generic doxepin product.
-
FDA approval · 2016-01-12FDA Approved: FLUOXETINE — Supplemental Application (Alembic Pharmaceuticals Limited)
FDA approved a supplemental application for fluoxetine from Alembic Pharmaceuticals Limited.
-
FDA approval · 2016-01-05FDA Approved: ESCITALOPRAM OXALATE — Supplemental Application (Rising Pharma Holdings, Inc.)
The FDA approved a supplemental application for Escitalopram Oxalate from Rising Pharma Holdings, Inc., confirming continued approval of thi…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2016-01-04FDA Approved: QUETIAPINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for a generic quetiapine product from Teva Pharmaceuticals USA, Inc.
-
FDA approval · 2015-12-30FDA Approved: REMERON — Supplemental Application (Organon LLC)
The FDA approved a supplemental application for REMERON (mirtazapine) submitted by Organon LLC.
-
FDA approval · 2015-12-23FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved a supplemental application for sertraline hydrochloride (Lupin Pharmaceuticals, Inc.), a generic product under an ANDA.
-
FDA approval · 2015-12-22FDA Approved: DULOXETINE DELAYED-RELEASE — Supplemental Application (Breckenridge Pharmaceutical, Inc.)
The FDA approved Breckenridge Pharmaceutical's supplemental application for a duloxetine hydrochloride delayed-release product, granting app…
-
FDA approval · 2015-12-15FDA Approved: CITALOPRAM HYDROBROMIDE — Original Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' generic citalopram hydrobromide tablets under an Original Application (ANDA) for major depressive disor…
-
FDA approval · 2015-12-03FDA Approved: MIRTAZAPINE — Supplemental Application (Apotex Corp.)
The FDA approved a supplemental application for Apotex Corp. to market a generic formulation of mirtazapine.
-
FDA approval · 2015-12-01FDA Approved: CITALOPRAM — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for Citalopram by Mylan Pharmaceuticals Inc., signaling an approved update to the existing generic p…
-
FDA approval · 2015-11-24FDA Approved: PROZAC — Supplemental Application (Dista Products Company)
FDA approved a supplemental application for Prozac (fluoxetine hydrochloride) submitted by Dista Products Company.
-
FDA approval · 2015-11-12FDA Approved: ESCITALOPRAM — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for escitalopram oxalate manufactured by Aurobindo Pharma Limited, updating the existing approval fo…
-
FDA approval · 2015-11-10FDA Approved: BUPROPION — Supplemental Application (Zydus Pharmaceuticals USA Inc.)
FDA approved a supplemental application for Bupropion submitted by Zydus Pharmaceuticals USA Inc. The approval indicates changes to the prod…
-
FDA approval · 2015-10-28FDA Approved: ESCITALOPRAM — Supplemental Application (Jubilant Cadista Pharmacuticals Inc.)
The FDA approved Jubilant Cadista's supplemental application for escitalopram oxalate, a generic version of escitalopram.
-
FDA approval · 2015-10-28FDA Approved: DULOXETINE — Original Application (ANI Pharmaceuticals, Inc.)
The FDA approved ANI Pharmaceuticals' original ANDA for duloxetine, allowing a generic version to be marketed. The approval covers duloxetin…
-
FDA approval · 2015-10-23FDA Approved: ESCITALOPRAM ORAL SOLUTION — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for escitalopram oral solution from Chartwell RX, LLC, enabling a generic oral formulation. This app…
-
FDA approval · 2015-10-16FDA Approved: EMSAM — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental application for EMSAM (selegiline transdermal patch) from Viatris Specialty LLC.
-
FDA approval · 2015-10-05FDA Approved: OLANZAPINE AND FLUOXETINE — Supplemental Application (Par Health USA, LLC)
FDA approved a supplemental application for the olanzapine and fluoxetine combination (Symbyax) submitted by Par Health USA, LLC.
-
FDA approval · 2015-09-30FDA Approved: ARIPIPRAZOLE — Original Application (Apotex Corp.)
FDA approved Apotex Corp.'s Original Application for aripiprazole, granting approval of a generic version of the antipsychotic.
-
FDA approval · 2015-09-11FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for generic bupropion hydrochloride from Aurobindo Pharma Limited, confirming continued approval and…
-
FDA approval · 2015-09-09FDA Approved: ESCITALOPRAM OXALATE — Supplemental Application (Macleods Pharmaceuticals Limited)
FDA approved a supplemental application for escitalopram oxalate by Macleods Pharmaceuticals Limited.
-
FDA approval · 2015-09-04FDA Approved: QUETIAPINE FUMARATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for quetiapine fumarate from Hikma Pharmaceuticals USA, indicating approval of changes to the pr…
-
FDA approval · 2015-08-28FDA Approved: ESCITALOPRAM — Original Application (SOLCO HEALTHCARE US, LLC)
The FDA approved an original application for a generic escitalopram product from Solco Healthcare US, LLC, for the treatment of major depres…